Felicia Davatolhagh is a postdoctoral researcher at the University of California, Los Angeles in Anne Churchland’s lab, where she studies how cortical circuits are altered during decision-making in a genetic mouse model of autism. She also serves as a member of the neurobiology department’s Justice, Diversity and Inclusion (JEDI) group.
![Headshot of Felicia Davatolhagh.](https://www.thetransmitter.org/wp-content/uploads/2024/07/Davatolhagh-Felicia-SURFSynposium-April2023-emilyvtan.jpg)
Felicia Davatolhagh
Postdoctoral researcher
University of California, Los Angeles
From this contributor
Women are systematically under-cited in neuroscience. New tools can change that.
An omitted citation in a high-profile paper led us to examine our own practices and to help others adopt tools that promote citation diversity.
![Photograph of a pink pencil standing out from a row of blue pencils.](https://www.thetransmitter.org/wp-content/uploads/2024/07/CitationBias-landscape-1200-1024x692.png)
Women are systematically under-cited in neuroscience. New tools can change that.
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.